Dr. Maitreyee Bhattacharyya is a consultant in Clinical Haematology at Manipal Hospitals, Mukundapur, Kolkata, with over 25 years of experience. She is the first DM Haematologist from Eastern India and initiated the first Bone Marrow Transplant in a government hospital. Her professional work includes patient care, teaching, and research. She is involved in national advisory responsibilities and postgraduate academic mentorship in haematology.

Educational Qualifications

• MBBS
• MD (Medicine)
• DM (Clinical Haematology)

Professional Experience

• Consultant – Haematology Specialist, Manipal Hospitals, Mukundapur, Kolkata
• Over 25 years of experience in Clinical Haematology
• Postdoctoral Teacher
• PhD Guide

Awards & Achievements

• First DM in Haematology from Eastern India
• Initiated Bone Marrow Transplant (BMT) in a government setup
• Postdoctoral Teacher and PhD Guide

Professional Memberships

• Scientific Advisory Committee (SAC), National Institute of Immuno Hematology, Mumbai

Publications

• Neonatal thrombosis in India—a report of 14 cases.
  Thrombosis Research, 2003; 111(3):191–192.
• Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India.
  American Journal of Clinical Pathology, 2004; 121(6):844–847.
• Clinico-hematological spectrum of patients with lupus anticoagulant.
  Clinical and Applied Thrombosis/Hemostasis, 2005; 11(2):191–195.
• Protein C system defect in Indian children with thrombosis.
  Annals of Hematology, 2005; 84:85–88.
• Clinical, haematological and histomorphological profile of adult myelodysplastic syndrome: Study of 96 cases in a single institute.
  European Journal of Haematology, 2004; 73(2):93–97.
• Prevalence of hemoglobinopathies in rural Bengal, India.
  Hemoglobin, 2012; 36(1):57–63.
• Lenalidomide-Induced Pure Red Cell Aplasia.
  Turkish Journal of Haematology, 2014; 31(1):99–100.
• Atypical HUS caused by anti-complement factor H antibody: a hematologist’s perspective.
  Blood Research, 2015; 50(1):63–65.
• Intracellular iron overload leading to DNA damage in lymphocytes and immune dysfunction in thalassemia major.
  European Journal of Haematology, 2017; 99(5):399–408.
• Management of lymphomas: Consensus document by an Indian expert group.
  Indian Journal of Hematology and Blood Transfusion, 2018.
• Genetic determinants related to pharmacological induction of foetal haemoglobin in HbE/β-thalassemia.
  Annals of Hematology, 2019; 98(2):289–299.
• Bendamustine-Rituximab in Young CLL: Relevance in the Era of Small Molecule Inhibitors.
  Indian Journal of Hematology and Blood Transfusion, 2023.